デフォルト表紙
市場調査レポート
商品コード
1696296

微生物培養の世界市場:2025年~2033年

Global Microbiology Culture Market - 2025-2033


出版日
ページ情報
英文 180 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
微生物培養の世界市場:2025年~2033年
出版日: 2025年03月25日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の微生物培養の市場規模は、2024年に203億8,000万米ドルに達し、2033年には402億米ドルに達すると予測され、予測期間の2025年~2033年のCAGRは7.2%となる見込みです。

微生物培養は、微生物を培養して、その正体やサンプル中の存在量、あるいはその両方を調べる方法です。微生物学における主要な診断方法の一つです。微生物培養を行うには、pH、大気ガス、温度、圧力が制御された適切な物理的環境が必要です。微生物培養のための培地の調製には、栄養素、緩衝剤、浸透圧バランス調整剤、選択的阻害剤や指示薬を混合し、微生物の増殖と分化をサポートする寒天やブロスを作ることが含まれます。この工程は、腐敗微生物や病原微生物をモニタリングするための微生物学的検査では日常的な作業です。

最も一般的な方法は、寒天ベースの増殖培地を入れたペトリ皿をインキュベーター内で使用する方法です。もう一つの方法は液体培養で、細菌を液体栄養培地に懸濁して培養し、均一性を保つためにしばしば振盪します。

結核、デング熱、肺炎、血流感染、院内感染など、細菌、ウイルス、真菌による感染症が増加する中、これらの病原体を検出・研究するための微生物培養の必要性が高まっています。例えば、世界保健機関(WHO)によると、2023年には世界で推定1,080万人が結核に罹患し、その内訳は男性600万人、女性360万人、子供130万人です。結核はあらゆる国や年齢層で蔓延しており、単一の感染症による死因の第一位として世界的に返り咲いた可能性が高いです。

結核が広く蔓延し、薬剤耐性結核菌の脅威が高まる中、微生物培養技術は、この持続的な公衆衛生の課題との闘いにおいて、正確な診断、薬剤感受性試験、治療モニタリングに不可欠であるため、その需要は拡大すると予想されます。アウトブレイクの早期発見と制御に対するニーズの高まりは、微生物培養市場をさらに強化しています。

製造業者はFDA、EMA、ISOなどの規制機関によって設定された厳格な品質、安全性、性能基準を遵守しなければならないため、培地製造に関する厳しい規制枠組みは微生物培養市場にとって大きな抑制要因となり得ます。

これらの規制は、広範なバリデーション、無菌試験、品質管理手順を必要とし、新しい培地製品の製造コストと市場投入までの時間を増加させます。このようなコストは、高度な微生物学システムや異なる組成の微生物学培養を革新しようとしている複数の市場参入企業にとって障壁となる可能性があります。

当レポートでは、世界の微生物培養市場について調査し、市場の概要とともに、製品タイプ別、培養タイプ別、一貫性別、用途別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 エグゼクティブの洞察と重要なポイント

第3章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第5章 微生物培養市場、製品タイプ別

  • 培養装置
    • バイオリアクター
      • バイオリアクター装置
      • 計測機器
      • PHセンサー
      • 溶存酸素センサー
      • 温度センサー
      • その他
      • 分析装置
      • 細胞カウンター
      • 分光計
      • その他
      • 滅菌装置
      • インキュベーター
      • その他
  • 培養補助器具
  • 計測機器
    • PHセンサー
    • 温度センサー
    • 溶存酸素センサー
    • その他
  • 培養器具
    • ペトリ皿
    • ループと針
    • マイクロピペット
    • 遠心分離機
    • その他
  • 分析装置
    • 細胞カウンター
    • 分光計
    • その他

第6章 微生物培養市場、培養タイプ別

  • 真核生物の培養
  • 細菌培養

第7章 微生物培養市場、一貫性別

  • 液体培地
  • 固形培地
  • 半固形培地

第8章 微生物培養市場、用途別

  • 医薬品
  • 食品・飲料
  • その他
  • 水質検査
  • 化粧品

第9章 微生物培養市場、地域別市場分析と成長機会

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第10章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要な市場参入企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第11章 企業プロファイル

  • Danaher(Cytiva)
    • 会社概要
    • 製品ポートフォリオ
    • 財務概要
    • 主な発展
    • SWOT分析
  • BD
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Eiken Chemical co. Lti.
  • HiMedia Laboratories Pvt. Ltd
  • Kerry Group Plc
  • BioMerieux SA
  • Mettler Toledo
  • Yokogawa Electric Corporation
  • Conda Laboratories SA
  • SATAKE MultiMix Corporation
  • BE MARUBISHI CO., LTD.
  • ABLE Corporation &Biott Corporation

第12章 仮定と調査手法

第13章 付録

目次
Product Code: PH4443

The global microbiology culture market reached US$ 20.38 billion in 2024 and is expected to reach US$ 40.20 billion by 2033, growing at a CAGR of 7.2% during the forecast period 2025-2033.

A microbiology culture, or microbial culture, is a method of growing a microbial organism to determine its identity, its abundance in a sample, or both. It is one of the primary diagnostic methods in microbiology. Growing a microbial culture requires an appropriate physical environment with controlled pH, atmospheric gases, temperature, and pressure. Microbial culture media preparation involves mixing nutrients, buffering agents, osmotic balance regulators, and selective inhibitors or indicators to create agar or broth that supports microbial growth and differentiation. This process is a routine task in microbiological testing for monitoring spoilage and pathogenic microbes.

The most common method is using Petri dishes with agar-based growth medium, typically in an incubator. Another method is liquid culture, where bacteria are grown suspended in a liquid nutrient medium, often shaken to maintain uniformity.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Infectious Diseases

With the increasing incidence of bacterial, viral, and fungal infections, such as tuberculosis, dengue, pneumonia, bloodstream infections, and hospital-acquired infections, there is a growing need for microbial cultures to detect and study these pathogens. For instance, according to the World Health Organization in 2023, an estimated 10.8 million people worldwide fell ill with tuberculosis (TB), including 6.0 million men, 3.6 million women, and 1.3 million children. TB is present across all countries and age groups, and it has likely returned as the leading cause of death from a single infectious agent globally.

With its widespread prevalence and the increasing threat of drug-resistant TB strains, the demand for microbiological culture techniques is expected to grow, as they remain essential for accurate diagnosis, drug susceptibility testing, and treatment monitoring in combating this persistent public health challenge. The growing need for early detection and control of the outbreaks further strengthens the microbiology culture market.

Stringent Regulatory Framework for Culture Media Production

Stringent regulatory framework for culture media production could be a significant restraint for the microbiology culture market, as manufacturers must comply with strict quality, safety, and performance standards set by regulatory bodies like the FDA, EMA, and ISO.

These regulations require extensive validation, sterility testing, and quality control procedures, increasing production costs and time-to-market for new culture media products. These costs could be barrier to several market players who are innovating advanced microbiology systems or microbiology cultures with different compositions.

Segment Analysis

The global microbiology culture market is segmented based on the product type, culture type, consistency, application, and region.

Culture equipment in the product type segment is expected to dominate the microbiology culture market

Culture equipment plays a crucial role in the microbiology culture market by enabling precise microbial growth, monitoring, and analysis across various industries, including pharmaceuticals, clinical diagnostics, and food safety. Culture equipment comprises incubators, bioreactors, analytical devices, sterilization equipment, and others. Bioreactors are essential in microbiology culture, enabling the controlled growth of cells and microorganisms for drug production, vaccine development, and research. Sterilization equipment also plays a critical role in the microbiological culture market, as it ensures the prevention of contamination and maintains the integrity of cell cultures, which is essential for accurate research and experimentation.

Mergers and acquisitions (M&A) and collaborations play a crucial role in driving growth, innovation, and market expansion in the culture incubator and microbiology culture equipment sectors. For instance, in January 2023, Culture Biosciences and Cytiva teamed up to enhance upstream bioprocessing by integrating Culture's 250mL and 5L single-use bioreactors into Cytiva's Bioreactor Scaler tool. The 250mL bioreactors, mounted in mobile cart modules of four, support mammalian cell culture and microbial fermentation.

Geographical Analysis

North America is expected to dominate the microbiology culture market

North America, particularly the United States and Canada, holds a dominant position in the global microbiology culture market. The region's robust healthcare systems, including hospitals, clinics, and diagnostic laboratories, fuel the need for microbiology culture products.

Moreover, the rising prevalence of infectious diseases and the increasing focus on antimicrobial resistance further drive the market growth in the region. For instance, the Centers for Disease Control and Prevention (CDC) estimates that Salmonella causes approximately 1.35 million infections annually in the United States. This widespread bacterial infection is one of the country's most common causes of foodborne illness. It leads to about 26,500 hospitalizations and 420 deaths each year.

With this high incidence of Salmonella infections, there is a higher demand for microbiology cultures to detect pathogens in food, water, and clinical samples. Laboratories use microbiology culture media to grow and identify harmful microorganisms, leading to more sales of specialized culture products and testing kits.

The rising adoption of personalized medicine and microbial-based therapeutics is driving market expansion by enabling targeted treatments tailored to individual patient needs. Thus, the above factors are expected to drive the region's growth by solidifying the region's growth in the global microbiology culture market.

Competitive Landscape

The global market players in the microbiology culture market are Danaher (Cytiva), BD, Merck KGaA, Thermo Fisher Scientific Inc., Sartorius AG, Eiken Chemical co. Lti., HiMedia Laboratories Pvt. Ltd, Kerry Group Plc, BioMerieux S.A., Mettler Toledo, Yokogawa Electric Corporation, Conda Laboratories S.A, SATAKE MultiMix Corporation, B.E. MARUBISHI CO., LTD., and ABLE Corporation & Biott Corporation among others.

Key Developments

  • In November 2024, Dedalus Group and Ibex Medical Analytics have launched a fully integrated End-to-End AI-powered Digital Pathology Solution for cancer diagnosis, now commercially available in major European markets. The solution sets a new standard for anatomic pathology lab digitization by seamlessly integrating Ibex's GalenTM platform into Dedalus' comprehensive Digital Pathology (DP) Solution.
  • In September 2024, Roche has expanded its digital pathology open environment with over 20 AI algorithms from eight new collaborators, aiming to support pathologists and scientists in cancer research and diagnosis by leveraging advanced AI technology

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global microbiology culture market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Culture Type
  • 2.5. Snippet by Consistency
  • 2.6. Snippet by Application
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Infectious Diseases
      • 3.1.1.2. Increasing R&D Investments in Microbiology and Life Sciences
    • 3.1.2. Restraints
      • 3.1.2.1. Stringent Regulatory Framework for Culture Media Production
      • 3.1.2.2. Risk of Contamination and Inconsistent Results
    • 3.1.3. Opportunity
      • 3.1.3.1. Potential for Innovative Culture Media for Fastidious Microorganisms
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Microbiology Culture Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Culture Equipment*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Bioreactors
      • 5.2.3.1. Bioreactor Devices
      • 5.2.3.2. Measuring Instruments
      • 5.2.3.2.1. PH Sensors
      • 5.2.3.2.2. Dissolved Oxygen Sensors
      • 5.2.3.2.3. Temperature Sensors
      • 5.2.3.2.4. Others
      • 5.2.3.3. Analytical Devices
      • 5.2.3.3.1. Cell Counters
      • 5.2.3.3.2. Spectrometers
      • 5.2.3.3.3. Others
      • 5.2.3.4. Sterilization Equipment
      • 5.2.3.5. Incubators
      • 5.2.3.6. Others
  • 5.3. Culture Supplements
  • 5.4. Measuring Instruments
    • 5.4.1. PH Sensors
    • 5.4.2. Temperature Sensors
    • 5.4.3. Dissolved Oxygen Sensors
    • 5.4.4. Others
  • 5.5. Culture Instruments
    • 5.5.1. Petri Dishes
    • 5.5.2. Loops & Needles
    • 5.5.3. Micropipettes
    • 5.5.4. Centrifuge
    • 5.5.5. Others
  • 5.6. Analytical Devices
    • 5.6.1. Cell Counters
    • 5.6.2. Spectrometers
    • 5.6.3. Others

6. Microbiology Culture Market, By Culture Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 6.1.2. Market Attractiveness Index, By Culture Type
  • 6.2. Eukaryotic Culture*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Bacterial Culture

7. Microbiology Culture Market, By Consistency

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 7.1.2. Market Attractiveness Index, By Consistency
  • 7.2. Liquid Media*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Solid Culture Media
  • 7.4. Semi-solid Media

8. Microbiology Culture Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Pharmaceuticals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Food & Beverage Industry
  • 8.4. Others
  • 8.5. Water Testing
  • 8.6. Cosmetics

9. Microbiology Culture Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Mexico
      • 9.4.7.2. Brazil
      • 9.4.7.3. Argentina
      • 9.4.7.4. Rest of Latin America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Danaher (Cytiva)*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. BD
  • 11.3. Merck KGaA
  • 11.4. Thermo Fisher Scientific Inc.
  • 11.5. Sartorius AG
  • 11.6. Eiken Chemical co. Lti.
  • 11.7. HiMedia Laboratories Pvt. Ltd
  • 11.8. Kerry Group Plc
  • 11.9. BioMerieux S.A.
  • 11.10. Mettler Toledo
  • 11.11. Yokogawa Electric Corporation
  • 11.12. Conda Laboratories S.A
  • 11.13. SATAKE MultiMix Corporation
  • 11.14. B.E. MARUBISHI CO., LTD.
  • 11.15. ABLE Corporation & Biott Corporation

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us